Browsing by Author "Nachega JB"
Now showing 1 - 15 of 15
Results Per Page
Sort Options
- ItemAntifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis(Annals of Clinical Microbiology and Antimicrobials, 2009) Mills EJ; Perri D; Cooper C; Nachega JB; Wu P; Tleyjeh I; Phillips P
- ItemClinical aspects of tuberculosis in HIV-infected adults(2009) Nachega JB; Maartens G
- ItemGuidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel(AMER COLL PHYSICIANS, INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA,USA, PA, 19106-1572, 2012) Thompson MA; Mugavero MJ; Amico KR; Cargill VA; Chang LW; Gross R; Orrell C; Altice FL; Bangsberg DR; Bartlett JG; Beckwith CG; Dowshen N; Gordon CM; Horn T; Kumar P; Scott JD; Stirratt MJ; Remien RH; Simoni JM; Nachega JB
- ItemImpact of timing of antiretroviral therapy initiation on survival of cervical squamous intraepithelial lesions: a cohort analysis from South Africa(ROYAL SOC MEDICINE PRESS LTD, 1 WIMPOLE STREET, LONDON, ENGLAND, W1G 0AE, 2012) Zeier MD; Nachega JB; Van der Merwe FH; Eshun-Wilson I; Van Schalkwyk M; La Grange M; Mason D; Louw M; Botha MH
- ItemOral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs(2013) Gupta RK; Wainberg MA; Brun-Vezinet F; Gatell JM; Albert J; S�nnerborg A; Nachega JB
- ItemProphylaxis with antituberculous drugs in special situations(2009) Apers L; Robert C; Nachega JB
- ItemRapid diagnostic tests for diagnosing uncomplicated Plasmodium falciparum malaria in endemic countries (review)(OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP, 2012) Bottieau, Emmanuel; Jacobs J; Nachega JB
- ItemRisk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study(2013) Ndiaye M; Nyasulu P; Nguyen H; Lowenthal ED; Gross R; Mills EJ; Nachega JB
- ItemSafety and effectiveness of efavirenz versus nevirapine-based regimens in resource-limited settings: evidence, clinical practice and modelling projections(LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA,19106-3621, 2012) Uthman OA; Mofenson LM; Nachega JB
- ItemSecond-line antiretroviral therapy: Long-term outcomes in South Africa(LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA,19106-3621, 2012) Murphy RA; Sunpath H; Castilla C; Ebrahim S; Court R; Nguyen H; Kuritzkes DR; Marconi VC; Nachega JB
- ItemSub-optimal CD4 T-lymphocyte responses among HIV infected patients who develop TB during the first year of ART(2012) Eshun-Wilson I; Taljaard JJ; Nachega JB
- ItemTargeting tuberculosis and HIV/AIDS: a global progress report of a deadly partnership.(Infectious Disorders - Drug Targets, 2011) Nachega JB; Rosenkranz B
- ItemThe prevalence of refractive error in three communities of Cape Town, South Africa(The South African Optometrist, Official Journal of the South African Optometrist Association, Department of Optometry, RAU, P.O. Box 524, Auckland Park, 2006, South Africa, Fax: 011 489 2091, 2012) Otutu M; Nachega JB; Harvey J; Meyer D
- ItemTreatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs(Patient Preference and Adherence, 2011) Nachega JB; Mugavero MJ; Zeier MD; Vit??ria M; Gallant JE
- ItemTwice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?(Patient Preference and Adherence, 2011) Nachega JB; Rosenkranz B; Pham PA